$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Current update on established and novel biomarkers in salivary gland carcinoma pathology and the molecular pathways involved

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS), v.266 no.3, 2009년, pp.333 - 341  

Stenner, Markus ,  Klussmann, J. Peter

초록이 없습니다.

참고문헌 (70)

  1. VL Vander Poorten 222 2002 Salivary gland carcinoma-stepping up the prognostic ladder Vander Poorten VL (2002) Salivary gland carcinoma-stepping up the prognostic ladder. University of Amsterdam, Amsterdam, p 222 

  2. Barnes L, Eveson JW, Reichart P et al (eds) (2005) Tumors of the salivary gland. In: Pathology and genetics. Head and neck tumors. World health organization classification of tumors. IARC Press, Lyon, 209-281 

  3. Histopathology W Cheuk 51 1 1 2007 10.1111/j.1365-2559.2007.02719.x Cheuk W, Chan JK (2007) Advances in salivary gland pathology. Histopathology 51(1):1-20 

    상세보기 crossref

  4. Acta Otolaryngol H Luukkaa 125 2 207 2005 10.1080/00016480510003174 Luukkaa H, Klemi P, Leivo I et al (2005) Salivary gland cancer in Finland 1991-96: an evaluation of 237 cases. Acta Otolaryngol 125(2):207-214 

    상세보기 crossref

  5. Acta Oncol I Leivo 45 6 662 2006 10.1080/02841860600801316 Leivo I (2006) Insights into a complex group of neoplastic disease: advances in histopathologic classification and molecular pathology of salivary gland cancer. Acta Oncol 45(6):662-668. doi: 10.1080/02841860600801316 

    상세보기 crossref

  6. Med Electron Microsc T Yamamoto 34 207 2001 10.1007/s007950100017 Yamamoto T, Tanigawa N (2001) The role of survivin as a new target of diagnosis and treatment in human cancer. Med Electron Microsc 34:207-212. doi: 10.1007/s007950100017 

    crossref

  7. Cancer Res M Schmitz 60 4845 2000 Schmitz M, Diestelkoetter P, Weigle B et al (2000) Generation of survivin-specific CD8CT effector cells by dendritic cells pulsed with protein or selected peptides. Cancer Res 60:4845-4849 

    상세보기

  8. Br J Cancer SF Preuss 98 3 627 2008 10.1038/sj.bjc.6604192 Preuss SF, Weinell A, Molitor M et al (2008) Nuclear survivin expression is associated with HPV-independent carcinogenesis and is an indicator of poor prognosis in oropharyngeal cancer. Br J Cancer 98(3):627-632 

    상세보기 crossref

  9. Br J Cancer O Ben-Izhak 96 7 1101 2007 10.1038/sj.bjc.6603655 Ben-Izhak O, Laster Z, Araidy S et al (2007) TUNEL-an efficient prognosis predictor of salivary malignancies. Br J Cancer 96(7):1101-1106 

    상세보기 crossref

  10. Oncology RM Nagler 64 4 389 2003 10.1159/000070298 Nagler RM, Kerner H, Ben-Eliezer S et al (2003) Prognostic role of apoptotic, Bcl-2, c-erbB-2 and p53 tumor markers in salivary gland malignancies. Oncology 64(4):389-398. doi: 10.1159/000070298 

    상세보기 crossref

  11. Immunity RH Vonderheide 10 673 1999 10.1016/S1074-7613(00)80066-7 Vonderheide RH, Hahn WC, Schultze JL et al (1999) The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes. Immunity 10:673-679. doi: 10.1016/S1074-7613(00)80066-7 

    상세보기 crossref

  12. Am J Surg AJ Durkin 186 431 2003 10.1016/j.amjsurg.2003.07.008 Durkin AJ, Bloomston PM, Rosemurgy AS et al (2003) Defining the role of the epidermal growth factor receptor in pancreatic cancer grown in vitro. Am J Surg 186:431-436. doi: 10.1016/j.amjsurg.2003.07.008 

    상세보기 crossref

  13. Oral Oncol RL Dodd 42 8 759 2006 10.1016/j.oraloncology.2006.01.001 Dodd RL, Slevin NJ (2006) Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies. Oral Oncol 42(8):759-769 

    상세보기 crossref

  14. Drugs Today (Barc) J Harding 41 107 2005 10.1358/dot.2005.41.2.882662 Harding J, Burtness B (2005) Cetuximab: an epidermal growth factor receptor chimeric human-murine monoclonal antibody. Drugs Today (Barc) 41:107-127. doi: 10.1358/dot.2005.41.2.882662 

    상세보기 crossref

  15. Pancreas M Mimeault 31 4 301 2005 10.1097/01.mpa.0000175893.04660.1b Mimeault M, Brand RE, Sasson AA et al (2005) Recent advances on the molecular mechanisms involved in pancreatic cancer progression and therapies. Pancreas 31(4):301-316 

    상세보기 crossref

  16. Head Neck M Vered 24 632 2002 10.1002/hed.10104 Vered M, Braunstein E, Buchner A (2002) Immunohistochemical study of epidermal growth factor receptor in adenoid cystic carcinoma of salivary gland origin. Head Neck 24:632-636. doi: 10.1002/hed.10104 

    상세보기 crossref

  17. Cell GD Yancopoulos 93 5 661 1998 10.1016/S0092-8674(00)81426-9 Yancopoulos GD, Klagsbrun M, Folkman J (1998) Vasculogenesis, angiogenesis, and growth factors: ephrins enter the fray at the border. Cell 93(5):661-664 

    상세보기 crossref

  18. Anticancer Res P Lequerica-Fernández 27 5B 3661 2007 Lequerica-Fernández P, Astudillo A, de Vicente JC (2007) Expression of vascular endothelial growth factor in salivary gland carcinomas correlates with lymph node metastasis. Anticancer Res 27(5B):3661-3666 

  19. Head Neck KJ Cho 21 414 1999 10.1002/(SICI)1097-0347(199908)21:5<414::AID-HED6>3.0.CO;2-M Cho KJ, Lee SS, Lee YS (1999) Proliferating cell nuclear antigen and C-erbB-2 oncoprotein expression in adenoid cystic carcinomas of the salivary glands. Head Neck 21:414-419 doi :10.1002/(SICI)1097-0347(199908)21:5<414::AID-HED6>3.0.CO;2-M 

    상세보기 crossref

  20. Histopathology A Skálová 42 1 2003 10.1046/j.1365-2559.2003.01600.x Skálová A, Starek I, Vanecek T et al (2003) Expression of HER-2/neu gene and protein in salivary duct carcinomas of parotid gland as revealed by immunofluorescence in situ hybridization and immunohistochemistry. Histopathology 42:1-9. doi: 10.1046/j.1365-2559.2003.01600.x 

    상세보기 crossref

  21. Pathol Res Pract A Skálová 197 621 2001 10.1078/0344-0338-00136 Skálová A, Starek , Kucerova V et al (2001) Salivary duct carcinoma-highly aggressive salivary gland tumor with HER-2/neu oncoprotein overexpression. Pathol Res Pract 197:621-626. doi: 10.1078/0344-0338-00136 

    상세보기 crossref

  22. J Clin Pathol A Etges 56 12 914 2003 10.1136/jcp.56.12.914 Etges A, Pinto DS Jr, Kowalski LP et al (2003) Salivary duct carcinoma: immunohistochemical profile of an aggressive salivary gland tumor. J Clin Pathol 56(12):914-918 

    상세보기 crossref

  23. Laryngorhinootologie M Jaehne 80 525 2001 10.1055/s-2001-17088 Jaehne M, Jäkel KT, Röser K et al (2001) About the prognostic value of Her-2 gene-amplification and cell-proliferation in salivary duct carcinoma of the major salivary glands-a pilot-study. Laryngorhinootologie 80:525-529. doi: 10.1055/s-2001-17088 

    상세보기 crossref

  24. Cancer M Jaehne 103 12 2526 2005 10.1002/cncr.21116 Jaehne M, Roeser K, Jaekel T et al (2005) Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases. Cancer 103(12):2526-2533 

    상세보기 crossref

  25. Cytometry H Dong 28 280 1997 10.1002/(SICI)1097-0320(19970801)28:4<280::AID-CYTO2>3.0.CO;2-G Dong H, Bertler C, Schneider E et al (1997) Assessment of cell proliferation by AgNOR scores and Ki-67 labeling indices and a comparison with potential doubling times. Cytometry 28:280-288 doi :10.1002/(SICI)1097-0320(19970801)28:4<280::AID-CYTO2>3.0.CO;2-G 

    상세보기 crossref

  26. Ann Oncol A Pich 15 9 1319 2004 10.1093/annonc/mdh299 Pich A, Chiusa L, Navone R (2004) Prognostic relevance of cell proliferation in head and neck tumors. Ann Oncol 15(9):1319-1329 

    상세보기 crossref

  27. Oral Dis K Triantafillidou 12 4 364 2006 10.1111/j.1601-0825.2005.01166.x Triantafillidou K, Dimitrakopoulos J, Iordanidis F et al (2006) Mucoepidermoid carcinoma of minor salivary glands: a clinical study of 16 cases and review of the literature. Oral Dis 12(4):364-370 

    상세보기 crossref

  28. Hum Pathol A Skálová 25 9 929 1994 10.1016/0046-8177(94)90014-0 Skálová A, Lehtonen H, von Boguslawsky K et al (1994) Prognostic significance of cell proliferation in mucoepidermoid carcinomas of the salivary gland: clinicopathological study using MIB 1 antibody in paraffin sections. Hum Pathol 25(9):929-935. doi: 10.1016/0046-8177(94)90014-0 

    상세보기 crossref

  29. Oral Oncol T Kiyoshima 37 3 315 2001 10.1016/S1368-8375(00)00083-X Kiyoshima T, Shima K, Kobayashi I et al (2001) Expression of p53 tumor suppressor gene in adenoid cystic and mucoepidermoid carcinomas of the salivary glands. Oral Oncol 37(3):315-322. doi: 10.1016/S1368-8375(00)00083-X 

    상세보기 crossref

  30. Acta Oncol H Luukkaa 45 6 669 2006 10.1080/02841860500543208 Luukkaa H, Klemi P, Leivo I et al (2006) Prognostic significance of Ki-67 and p53 as tumor markers in salivary gland malignancies in Finland: an evaluation of 212 cases. Acta Oncol 45(6):669-675. doi: 10.1080/02841860500543208 

    상세보기 crossref

  31. Laryngoscope S Nordgard 107 4 531 1997 10.1097/00005537-199704000-00019 Nordgard S, Franzen G, Boysen M et al (1997) Ki-67 as a prognostic marker in adenoid cystic carcinoma assessed with the monoclonal antibody MIB1 in paraffin sections. Laryngoscope 107(4):531-536. doi: 10.1097/00005537-199704000-00019 

    상세보기 crossref

  32. J Pathol HB Hellquist 181 323 1997 10.1002/(SICI)1096-9896(199703)181:3<323::AID-PATH780>3.0.CO;2-K Hellquist HB, Sundelin K, Di Bacco A et al (1997) Tumor growth fraction and apoptosis in salivary gland acinic cell carcinomas. Prognostic implications of Ki-67 and bcl-2 expression and of in situ end labelling (TUNEL). J Pathol 181:323-329 doi :10.1002/(SICI)1096-9896(199703)181:3<323::AID-PATH780>3.0.CO;2-K 

    상세보기 crossref

  33. Best Pract Res Clin Gastroenterol M Bhattacharyya 20 2 285 2006 10.1016/j.bpg.2005.10.004 Bhattacharyya M, Lemoine NR (2006) Gene therapy developments for pancreatic cancer. Best Pract Res Clin Gastroenterol 20(2):285-298 

    상세보기 crossref

  34. Am J Pathol HF Frierson Jr 161 4 1315 2002 10.1016/S0002-9440(10)64408-2 Frierson HF Jr, El-Naggar AK, Welsh JB et al (2002) Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma. Am J Pathol 161(4):1315-1323 

    상세보기 crossref

  35. Int J Cancer TL Lee 122 9 1987 2008 10.1002/ijc.23324 Lee TL, Yeh J, Friedman J et al (2008) A signal network involving coactivated NF-kappaB and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas. Int J Cancer 122(9):1987-1998 

    상세보기 crossref

  36. J Surg Oncol M Dong 82 111 2003 10.1002/jso.10186 Dong M, Nio Y, Yamasawa K et al (2003) p53 alteration is not an independent prognostic indicator, but affects the efficacy of adjuvant chemotherapy in human pancreatic cancer. J Surg Oncol 82:111-120. doi: 10.1002/jso.10186 

    상세보기 crossref

  37. Hum Pathol Y Yamamoto 27 782 1996 10.1016/S0046-8177(96)90449-9 Yamamoto Y, Kishimoto Y, Virmani AK et al (1996) Mutations associated with carcinomas arising from pleomorphic adenomas of the salivary glands. Hum Pathol 27:782-786. doi: 10.1016/S0046-8177(96)90449-9 

    상세보기 crossref

  38. J Cell Sci KM Yamada 114 2375 2001 10.1242/jcs.114.13.2375 Yamada KM, Araki M (2001) Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis. J Cell Sci 114:2375 

    상세보기 crossref

  39. Br J Cancer S Tomozawa 83 324 2000 10.1054/bjoc.2000.1270 Tomozawa S, Tsuno NH, Sunami E et al (2000) Cyclooxygenase-2 overexpression correlates with tumor recurrence, especially haematogenous metastasis, of colorectal cancer. Br J Cancer 83:324-328. doi: 10.1054/bjoc.2000.1270 

    상세보기 crossref

  40. Cancer Res Y Araki 63 728 2003 Araki Y, Okamura S, Hussain SP et al (2003) Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways. Cancer Res 63:728-734 

    상세보기

  41. Oral Oncol S Dori 36 450 2000 10.1016/S1368-8375(00)00029-4 Dori S, Trougouboff P, David R, Buchner A (2000) Immunohistochemical evaluation of estrogen and progesterone receptors in adenoid cystic carcinoma of salivary gland origin. Oral Oncol 36:450-453. doi: 10.1016/S1368-8375(00)00029-4 

    상세보기 crossref

  42. Arch Otolaryngol Head Neck Surg IW Dimery 113 1082 1987 10.1001/archotol.1987.01860100060022 Dimery IW, Jones LA, Verjan RP, Raymond AK, Goepfert H, Hong WK (1987) Estrogen receptors in normal salivary gland and salivary gland carcinoma. Arch Otolaryngol Head Neck Surg 113:1082-1085 

    상세보기 crossref

  43. Clin Otolaryngol JP Jeannon 24 1 52 1999 10.1046/j.1365-2273.1999.00211.x Jeannon JP, Soames JV, Bell H, Wilson JA (1999) Immunohistochemical detection of oestrogen and progesterone receptors in human salivary gland tumours. Clin Otolaryngol 24(1):52-54. doi: 10.1046/j.1365-2273.1999.00211.x 

    상세보기 crossref

  44. Am J Clin Pathol SM Nasser 119 6 801 2003 10.1309/RVTP1G0Q727WJUQD Nasser SM, Faquin WC, Dayal Y (2003) Expression of androgen, estrogen, and progesterone receptors in salivary gland tumors. Frequent expression of androgen receptor in a subset of malignant salivary gland tumors. Am J Clin Pathol 119(6):801-806. doi: 10.1309/RVTP1G0Q727WJUQD 

    상세보기 crossref

  45. Clin Cancer Res K Ohshiro 12 (20 Pt 1) 5994 2006 10.1158/1078-0432.CCR-06-1251 Ohshiro K, Rayala SK, Williams MD, Kumar R, El-Naggar AK (2006) Biological role of estrogen receptor beta in salivary gland adenocarcinoma cells. Clin Cancer Res 12 (20 Pt 1):5994-5999 

    상세보기 crossref

  46. Endocr Relat Cancer T Yoshimura 14 4 1107 2007 10.1677/erc.1.01253 Yoshimura T, Sumida T, Liu S, Onishi A, Shintani S, Desprez PY, Hamakawa H (2007) Growth inhibition of human salivary gland tumor cells by introduction of progesterone (Pg) receptor and Pg treatment. Endocr Relat Cancer 14(4):1107-1116. doi: 10.1677/erc.1.01253 

    상세보기 crossref

  47. CA Cancer J Clin A Jemal 55 10 2005 10.3322/canjclin.55.1.10 Jemal A, Murray T, Ward E et al (2005) Cancer statistics, 2005. CA Cancer J Clin 55:10-30 

    상세보기 crossref

  48. Best Pract Res Clin Gastroenterol G Gaudernack 20 2 299 2006 10.1016/j.bpg.2006.01.003 Gaudernack G (2006) Prospects for vaccine therapy for pancreatic cancer. Best Pract Res Clin Gastroenterol 20(2):299-314 

    상세보기 crossref

  49. J Pathol D Campani 194 4 444 2001 10.1002/path.925 Campani D, Esposito I, Boggi U et al (2001) Bcl-2 expression in pancreas development and pancreatic cancer progression. J Pathol 194(4):444-450 

    상세보기 crossref

  50. Gut H Friess 43 3 414 1998 10.1136/gut.43.3.414 Friess H, Lu Z, Graber HU et al (1998) Bax, but not bcl-2, influences the prognosis of human pancreatic cancer. Gut 43(3):414-421 

    상세보기 crossref

  51. Mol Cancer Ther MN Younes 5 11 2696 2006 10.1158/1535-7163.MCT-05-0228 Younes MN, Park YW, Yazici YD et al (2006) Concomitant inhibition of epidermal growth factor and vascular endothelial growth factor receptor tyrosine kinases reduces growth and metastasis of human salivary adenoid cystic carcinoma in an orthotopic nude mouse model. Mol Cancer Ther 5(11):2696-2705 

    상세보기 crossref

  52. N Engl J Med DJ Slamon 344 11 783 2001 10.1056/NEJM200103153441101 Slamon DJ, Leyland-Jones B, Shak S et al (2001) Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344(11):783-792. doi: 10.1056/NEJM200103153441101 

    상세보기 crossref

  53. J Clin Oncol M Agulnik 25 25 3978 2007 10.1200/JCO.2007.11.8612 Agulnik M, Cohen EW, Cohen RB et al (2007) Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands. J Clin Oncol 25(25):3978-3984 

    상세보기 crossref

  54. Int J Cancer MP Piechocki 119 2 441 2006 10.1002/ijc.21837 Piechocki MP, Yoo GH, Dibbley SK et al (2006) Iressa induces cytostasis and augments Fas-mediated apoptosis in acinic cell adenocarcinoma overexpressing HER2/neu. Int J Cancer 119(2):441-454 

    상세보기 crossref

  55. J Clin Oncol SJ Hotte 23 3 585 2005 10.1200/JCO.2005.06.125 Hotte SJ, Winquist EW, Lamont E et al (2005) Imatinib mesylate in patients with adenoid cystic carcinoma of the salivary glands expressing c-kit: a Princess Margaret Hospital Phase II consortium study. J Clin Oncol 23(3):585-590. doi: 10.1200/JCO.2005.06.125 

    상세보기 crossref

  56. Int J Pancreatol T Ohta 13 3 193 1993 10.1007/BF02924440 Ohta T, Nagakawa T, Tsukioka Y et al (1993) Expression of argyrophilic nucleolar organizer regions in ductal adenocarcinoma of the pancreas and its relationship to prognosis. Int J Pancreatol 13(3):193-200 

    상세보기 crossref

  57. Oncol Rep C Ferrara 6 5 1117 1999 Ferrara C, Tessari G, Poletti A et al (1999) Ki-67 and c-jun expression in pancreatic cancer: a prognostic marker? Oncol Rep 6(5):1117-1122 

  58. Am J Surg Pathol M Niedergethmann 26 1578 2002 10.1097/00000478-200212000-00005 Niedergethmann M, Rexin M, Hidenbrand R et al (2002) Prognostic implication of routine, immunohistochemical and molecular staging in respectable pancreatic adenocarcinoma. Am J Surg Pathol 26:1578-1587. doi: 10.1097/00000478-200212000-00005 

    상세보기 crossref

  59. Gut V Stoll 54 1 109 2005 10.1136/gut.2004.046706 Stoll V, Calleja V, Vassaux G et al (2005) Dominant negative inhibitors of signalling through the phosphoinositol 3-kinase pathway for gene therapy of pancreatic cancer. Gut 54(1):109-116 

    상세보기 crossref

  60. Clin Cancer Res S Yamamoto 10 2846 2004 10.1158/1078-0432.CCR-02-1441 Yamamoto S, Tomita Y, Hoshida Y et al (2004) Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma. Clin Cancer Res 10:2846-2850. doi: 10.1158/1078-0432.CCR-02-1441 

    상세보기 crossref

  61. Pancreas A Takeda 28 353 2004 10.1097/00006676-200404000-00026 Takeda A, Osaki M, Adachi K et al (2004) Role of the phosphatidylinositol 3′-kinase-Akt signal pathway in the proliferation of human pancreatic ductal carcinoma cell lines. Pancreas 28:353-358. doi: 10.1097/00006676-200404000-00026 

    상세보기 crossref

  62. Dig Dis Sci A Hakam 48 10 1972 2003 10.1023/A:1026122421369 Hakam A, Fang Q, Karl R et al (2003) Coexpression of IGF-1R and c-Src proteins in human pancreatic ductal adenocarcinoma. Dig Dis Sci 48(10):1972-1978 

    상세보기 crossref

  63. Cancer Contr D Coppola 7 5 421 2000 10.1177/107327480000700504 Coppola D (2000) Molecular prognostic markers in pancreatic cancer. Cancer Contr 7(5):421-427 

    상세보기 crossref

  64. Cancer Lett T Toyonaga 201 107 2003 10.1016/S0304-3835(03)00482-8 Toyonaga T, Nakano K, Nagano M et al (2003) Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer. Cancer Lett 201:107-116. doi: 10.1016/S0304-3835(03)00482-8 

    상세보기 crossref

  65. Oncogene J Sun 24 20 3236 2005 10.1038/sj.onc.1208470 Sun J, Blaskovich MA, Jove R et al (2005) Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity. Oncogene 24(20):3236-3245 

    상세보기 crossref

  66. J Hepatobiliary Pancreat Surg ST Dergham 5 3 269 1998 10.1007/s005340050045 Dergham ST, Dugan MC, Sarkar FH et al (1998) Molecular alterations associated with improved survival in pancreatic cancer patients treated with radiation or chemotherapy. J Hepatobiliary Pancreat Surg 5(3):269-272. doi: 10.1007/s005340050045 

    상세보기 crossref

  67. Am J Pathol RE Wilentz 156 1 37 2000 10.1016/S0002-9440(10)64703-7 Wilentz RE, Su GH, Dai JL et al (2000) Immunohistochemical labeling for Dpc4 mirrors genetic status in pancreatic adenocarcinoma. Am J Pathol 156(1):37-43 

    상세보기 crossref

  68. Cancer Invest LW Feurino 24 7 696 2006 10.1080/07357900600981398 Feurino LW, Fisher WE, Bharadwaj U et al (2006) Current update of cytokines in pancreatic cancer: pathogenic mechanisms, clinical indication, and therapeutic values. Cancer Invest 24(7):696-703 

    상세보기 crossref

  69. J Interferon Cytokine Res X Le 20 935 2000 10.1089/10799900050198372 Le X, Shi Q, Wang B et al (2000) Molecular regulation of constitutive expression of interleukin-8 in human pancreatic adenocarcinoma. J Interferon Cytokine Res 20:935. doi: 10.1089/10799900050198372 

    상세보기 crossref

  70. J Laryngol Otol A Shadaba 111 12 1186 1997 10.1017/S0022215100139684 Shadaba A, Gaze MN, Grant HR (1997) The response of adenoid cystic carcinoma to tamoxifen. J Laryngol Otol 111(12):1186-1189. doi: 10.1017/S0022215100139684 

    상세보기 crossref

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로